Brief: Centogene Receives FDA Emergency Use Authorization For Sars-Cov-2 Rt-Pcr Assay For Individuals Without Symptoms Or Other Reasons To Suspect Covid-19
Oct 19 (Reuters) - Centogene NV 39K.MU :
* CENTOGENE RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR
SARS-COV-2 RT-PCR ASSAY FOR INDIVIDUALS WITHOUT SYMPTOMS OR
OTHER REASONS TO SUSPECT COVID-19
* CENTOGENE NV - EUA PERMITS USAGE OF CENTOSURE FOR
INDIVIDUALS
WITHOUT ANY SYMPTOMS OR SUSPICION OF COVID-19
Source text for Eikon: ID:nGNX85f8xN
Further company coverage: 39K.MU
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crown LiquidationCo NV in liquidatie
See all newsBrief: Centogene Signs Strategic Transaction With Private Equity Group Charme Capital Partners
Brief: Centogene Announces Adoption Of All Resolutions Tabled At 2024 Annual General Meeting
Brief: Centogene NV Says Agreements With LIFERA Provides Funding In Aggregate Of About $20 Mln To Co
Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease
Brief: Centogene Receives Nasdaq Non-Compliance Notice